Peptide Reference Desk
Cerebrolysin is a peptide mixture: why a single sequence or purity number is the wrong specification
Cerebrolysin is a complex peptide preparation rather than one defined peptide. Batch characterization therefore requires a distribution-based analytical strategy.
The category error
Cerebrolysin is described as a porcine-brain-derived peptide preparation containing low-molecular-weight peptides and other small components. It is not one peptide with one sequence and one exact molecular mass. Catalog records that force it into a single-compound template create false precision.
What a mixture specification should describe
For a complex hydrolysate, the relevant question is whether the batch falls within a controlled compositional fingerprint. That calls for orthogonal methods rather than a single “99% HPLC” value.
| Analytical layer | Purpose |
|---|---|
| Size-exclusion or molecular-weight distribution | Controls the peptide-size envelope |
| LC-MS fingerprint | Compares reproducible feature patterns between lots |
| Amino-acid or peptide-content assay | Provides a quantitative composition measure |
| Residual protein, bioburden and endotoxin | Addresses process-related quality risks |
| Validated bioassay | Monitors a defined functional attribute, if justified |
Clinical literature needs jurisdiction attached
Cerebrolysin has clinical literature and market history in several countries, but regulatory authorization is jurisdiction-specific and does not equal FDA approval. Reviews across stroke, traumatic brain injury and cognitive disorders reach different conclusions because study quality, endpoints and risk of bias vary.
Do not compare it with Dihexa as if both were neat compounds
Dihexa is a defined synthetic molecule; Cerebrolysin is a process-defined mixture. Comparing dose labels, mass purity or mechanism slogans across the two obscures the most important difference: one can be specified structurally, while the other must be controlled through manufacturing consistency and fingerprints.
Verify with primary records
Use the primary paper, current regulator label or lot-linked analytical file for the claim it supports. A search result is a route to evidence, not the evidence itself.